TransCode Therapeutics (RNAZ) Short Interest Ratio & Short Volume $0.69 +0.00 (+0.07%) Closing price 04:00 PM EasternExtended Trading$0.69 0.00 (-0.03%) As of 05:19 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock TransCode Therapeutics Short Interest DataTransCode Therapeutics (RNAZ) has a short interest of 540,900 shares, representing 81.84% of the float (the number of shares available for trading by the public). This marks a 232.04% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.3, indicating that it would take 0.3 days of the average trading volume of 1.58 million shares to cover all short positions.Current Short Interest540,900 sharesPrevious Short Interest162,900 sharesChange Vs. Previous Month+232.04%Dollar Volume Sold Short$1.07 millionShort Interest Ratio0.3 Days to CoverLast Record DateFebruary 28, 2025Outstanding Shares696,000 sharesFloat Size660,900 sharesShort Percent of Float81.84%Today's Trading Volume4,248,712 sharesAverage Trading Volume1,584,554 sharesToday's Volume Vs. Average268% Short Selling TransCode Therapeutics? Sign up to receive the latest short interest report for TransCode Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartRNAZ Short Interest Over TimeRNAZ Days to Cover Over TimeRNAZ Percentage of Float Shorted Over Time Remove Ads TransCode Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 2/28/2025540,900 shares $1.07 million +232.0%81.8%0.3 $1.98 2/15/2025162,900 shares $1.69 million -55.8%24.7%0.1 $10.36 1/31/2025368,300 shares $2.78 million +355.3%55.7%0.2 $7.56 1/15/202580,900 shares $258,071.00 -9.7%11.6%0.2 $3.19 12/31/202489,600 shares $301,952.00 +71.0%12.9%1.5 $3.37 12/15/202452,400 shares $388,808.00 +184.8%7.5%0.9 $7.42 11/30/202418,400 shares $6.97 million -91.5%2.7%0.4 $378.97 11/15/2024215,500 shares $73,205.35 -71.0%1.3%0.1 $0.34 10/31/2024743,600 shares $345,774.00 -39.1%4.3%0.4 $0.47 10/15/20241,220,000 shares $901,580.00 -11.6%7.1%0.6 $0.74 Get the Latest News and Ratings for RNAZ and Related StocksEnter your email address below to receive the latest news and analysts' ratings for TransCode Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 9/30/20241,380,000 shares $787,980.00 +52.5%8.0%0.7 $0.57 9/15/2024904,700 shares $234,407.77 +224.7%5.3%0.6 $0.26 8/31/2024278,600 shares $73,383.24 +58.5%1.6%0.2 $0.26 8/15/2024175,800 shares $43,950.00 -89.3%1.0%0.2 $0.25 7/31/20241,640,000 shares $459,200.00 +6,539.7%9.6%1.1 $0.28 7/15/202424,700 shares $22,237.41 -85.2%0.4%0 $0.90 6/30/2024167,200 shares $168,036.00 -62.7%2.5%0.1 $1.01 6/15/2024448,500 shares $538,200.00 -56.0%6.9%0.4 $1.20 5/31/20241,020,000 shares $1.81 million +486.5%15.6%0.8 $1.78 5/15/2024173,900 shares $140,267.74 +16.2%2.7%0.1 $0.81 4/30/2024149,600 shares $90,822.16 +704.3%2.3%0.2 $0.61 4/15/202418,600 shares $9,975.18 -53.5%0.3%0 $0.54 3/31/202440,000 shares $27,320.00 -77.1%0.6%0.1 $0.68 3/15/2024174,800 shares $120,786.80 +71.4%2.7%0.3 $0.69 2/29/2024102,000 shares $71,869.20 -53.8%1.6%0.2 $0.70 2/15/2024220,900 shares $145,794.00 -70.8%3.4%0.4 $0.66 1/31/2024755,300 shares $521,912.30 +7,529.3%13.0%1.6 $0.69 1/15/20249,900 shares $49,500.00 -97.6%1.8%0 $5.00 12/31/2023405,000 shares $66,744.00 -7.4%N/A0.1 $0.16 12/15/2023437,500 shares $74,156.25 -31.3%2.0%0.1 $0.17 11/30/2023637,200 shares $156,751.20 +31.8%3.0%0.1 $0.25 11/15/2023483,300 shares $138,610.44 -63.4%2.5%0.1 $0.29 10/31/20231,320,000 shares $488,664.00 +562.0%7.4%0.2 $0.37 10/15/2023199,400 shares $86,100.92 +173.9%6.2%0 $0.43 9/30/202372,800 shares $36,596.56 -42.4%4.5%0 $0.50 9/15/2023126,400 shares $84,511.04 +418.0%7.1%0.1 $0.67 8/31/202324,400 shares $35,380.00 +1,255.6%1.7%0.2 $1.45 8/15/20231,800 shares $2,916.00 -87.8%0.1%0 $1.62 7/31/202314,700 shares $32,340.00 -85.5%2.5%0.1 $2.20 7/15/2023101,500 shares $257,810.00 +81.9%16.9%0.4 $2.54Trump’s Great Society (Ad)Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.Millions of Americans are about to be wiped out, while others could make a fortune… click here to ma 6/30/202355,800 shares $128,340.00 +14.6%9.3%0.2 $2.30 6/15/202348,700 shares $129,055.00 +79.7%8.1%0.2 $2.65 5/31/202327,100 shares $113,820.00 +22.1%4.4%0.2 $4.20 5/15/202322,200 shares $135,109.20 -96.6%N/A0.5 $6.09 4/30/2023653,200 shares $206,345.88 +2.7%5.6%0.4 $0.32 4/15/2023636,000 shares $250,965.60 +99.5%5.5%0.4 $0.39 3/31/2023318,800 shares $107,913.80 +21.0%2.8%0.2 $0.34 3/15/2023263,500 shares $91,618.95 -51.3%2.3%0.2 $0.35 2/28/2023541,400 shares $282,069.40 -42.9%4.7%0.1 $0.52 2/15/2023948,400 shares $635,428.00 +104.5%7.5%0.2 $0.67 1/31/2023463,700 shares $348,145.96 +0.8%5.3%0.2 $0.75 1/15/2023459,900 shares $281,458.80 -43.5%5.3%0.1 $0.61 12/30/2022814,100 shares $547,889.30 -22.5%9.4%0.3 $0.67 12/15/20221,050,000 shares $472,290.00 +2,849.4%12.1%0.4 $0.45 11/30/202235,600 shares $14,240.00 +368.4%0.4%0 $0.40 11/15/20227,600 shares $4,164.80 -96.5%0.1%0 $0.55 10/31/2022218,800 shares $147,033.60 +478.8%2.5%0.3 $0.67 10/15/202237,800 shares $41,995.80 -2.1%0.4%1.9 $1.11 9/30/202238,600 shares $42,460.00 +565.5%0.4%1.9 $1.10 9/15/20225,800 shares $6,728.00 -29.3%0.1%0.3 $1.16 8/31/20228,200 shares $9,840.00 +90.7%0.1%0.2 $1.20 8/15/20224,300 shares $5,547.00 -66.4%0.1%0.1 $1.29 7/31/202212,800 shares $18,176.00 +1.6%0.2%0.3 $1.42 7/15/202212,600 shares $16,632.00 +26.0%0.1%0.3 $1.32 6/30/202210,000 shares $12,600.00 +1.0%0.1%0.2 $1.26 6/15/20229,900 shares $12,573.00 -52.9%0.1%0.3 $1.27 5/31/202221,000 shares $38,640.00 -15.7%0.2%1.1 $1.84 5/15/202224,900 shares $56,025.00 -46.6%0.3%1.5 $2.25 4/30/202246,600 shares $127,218.00 +88.7%0.5%2.9 $2.73 4/15/202224,700 shares $70,814.90 -44.9%0.3%1.4 $2.87 3/31/202244,800 shares $129,024.00 +37.9%0.5%2 $2.88 3/15/202232,500 shares $70,200.00 -38.2%0.4%0.9 $2.16 2/28/202252,600 shares $112,038.00 -37.8%0.7%1.3 $2.13 2/15/202284,600 shares $181,044.00 -12.6%1.2%1.6 $2.14 1/31/202296,800 shares $222,640.00 -24.7%1.4%1.6 $2.30 1/15/2022128,500 shares $322,535.00 +51.4%1.8%1.6 $2.51 12/31/202184,900 shares $215,646.00 +0.7%1.2%0.7 $2.54 12/15/202184,300 shares $207,378.00 +157.0%1.2%0.3 $2.46 11/30/202132,800 shares $90,200.00 +32.8%0.5%0 $2.75 11/15/202124,700 shares $73,606.00 -86.7%0.4%0 $2.98 10/29/2021185,900 shares $526,097.00 -22.9%2.6%0 $2.83 10/15/2021241,100 shares $776,342.00 -47.1%3.4%0.1 $3.22 9/30/2021455,400 shares $1.36 million +1,350.3%6.4%0.1 $2.99 9/15/202131,400 shares $81,012.00 -39.7%0.4%0 $2.58 8/31/202152,100 shares $158,384.00 +128.5%0.7%0 $3.04 8/13/202122,800 shares $65,436.00 No Change0.4%0 $2.87 RNAZ Short Interest - Frequently Asked Questions What is TransCode Therapeutics' current short interest? Short interest is the volume of TransCode Therapeutics shares that have been sold short but have not yet been covered or closed out. As of February 28th, investors have sold 540,900 shares of RNAZ short. 81.84% of TransCode Therapeutics' shares are currently sold short. Learn More on TransCode Therapeutics' current short interest. What is a good short interest percentage for TransCode Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 81.84% of TransCode Therapeutics' floating shares are currently sold short. Is TransCode Therapeutics' short interest increasing or decreasing? TransCode Therapeutics saw a increase in short interest during the month of February. As of February 28th, there was short interest totaling 540,900 shares, an increase of 232.0% from the previous total of 162,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is TransCode Therapeutics' float size? TransCode Therapeutics currently has issued a total of 696,000 shares. Some of TransCode Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. TransCode Therapeutics currently has a public float of 660,900 shares. How does TransCode Therapeutics' short interest compare to its competitors? 81.84% of TransCode Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to TransCode Therapeutics: Protagenic Therapeutics, Inc. (1.86%), Cyclacel Pharmaceuticals, Inc. (2.15%), Vincerx Pharma, Inc. (9.99%), ZyVersa Therapeutics, Inc. (1.78%), Avenue Therapeutics, Inc. (3.43%), Vaccinex, Inc. (5.39%), Galmed Pharmaceuticals Ltd. (0.30%), Salarius Pharmaceuticals, Inc. (5.53%), Oncternal Therapeutics, Inc. (0.54%), Eterna Therapeutics Inc. (1.80%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($23.74 billion), iShares 20+ Year Treasury Bond ETF ($10.75 billion), MicroStrategy Incorporated ($6.56 billion), Apollo Global Management, Inc. ($5.40 billion), Charter Communications, Inc. ($4.57 billion), AppLovin Co. ($4.45 billion), Capital One Financial Co. ($4.33 billion), Super Micro Computer, Inc. ($4.23 billion), Schlumberger Limited ($3.22 billion), and Royal Caribbean Cruises Ltd. ($3.06 billion). View all of the most shorted stocks. What does it mean to sell short TransCode Therapeutics stock? Short selling RNAZ is an investing strategy that aims to generate trading profit from TransCode Therapeutics as its price is falling. RNAZ shares are trading down $0.43 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against TransCode Therapeutics? A short squeeze for TransCode Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of RNAZ, which in turn drives the price of the stock up even further. How often is TransCode Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RNAZ, twice per month. The most recent reporting period available is February, 28 2025. More Short Interest Resources from MarketBeat Related Companies Protagenic Therapeutics Short Interest Data Cyclacel Pharmaceuticals Short Interest Data Vincerx Pharma Short Interest Data ZyVersa Therapeutics Short Interest Data Avenue Therapeutics Short Interest Data Vaccinex Short Interest Data Galmed Pharmaceuticals Short Interest Data Salarius Pharmaceuticals Short Interest Data Oncternal Therapeutics Short Interest Data Eterna Therapeutics Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:RNAZ) was last updated on 3/25/2025 by MarketBeat.com Staff From Our PartnersYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TransCode Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TransCode Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
